Shopping Cart
Remove All
Your shopping cart is currently empty
sCNH240
😃Good
Catalog No. T204076Cas No. 1357746-77-0
Alias 2-Fluoro-N-[3-(3-thienyl)-5-isoxazolyl]benzenesulfonamide
sCNH240 (2-Fluoro-N-[3-(3-thienyl)-5-isoxazolyl]benzenesulfonamide) is a potential and selective Rv1625c/Cya activator with good cell permeability and oral activity, IC90=1.24 μM in cholesterol-supplemented 7H12 medium against Mycobacterium tuberculosis (Mtb) H37Rv strain, and inhibition of CYP2C19, CYP2C9 and hERG channels.
sCNH240
😃Good
Purity: 99.82%
Catalog No. T204076Alias 2-Fluoro-N-[3-(3-thienyl)-5-isoxazolyl]benzenesulfonamideCas No. 1357746-77-0
sCNH240 (2-Fluoro-N-[3-(3-thienyl)-5-isoxazolyl]benzenesulfonamide) is a potential and selective Rv1625c/Cya activator with good cell permeability and oral activity, IC90=1.24 μM in cholesterol-supplemented 7H12 medium against Mycobacterium tuberculosis (Mtb) H37Rv strain, and inhibition of CYP2C19, CYP2C9 and hERG channels.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $940 | - | In Stock | |
| 5 mg | $2,070 | - | In Stock | |
| 10 mg | $3,110 | - | In Stock | |
| 25 mg | $5,280 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.82%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | sCNH240 (2-Fluoro-N-[3-(3-thienyl)-5-isoxazolyl]benzenesulfonamide) is a potential and selective Rv1625c/Cya activator with good cell permeability and oral activity, IC90=1.24 μM in cholesterol-supplemented 7H12 medium against Mycobacterium tuberculosis (Mtb) H37Rv strain, and inhibition of CYP2C19, CYP2C9 and hERG channels. |
| Targets&IC50 | M. tuberculosis H37Rv:1.24 μM (MIC₉₀), Cytotoxicity:>40 μM (CC₅₀), M. tuberculosis (Intracellular):2.93 μM (EC₅₀) |
| In vitro | sCNH240 showed potent anti-TB activity against M. tuberculosis H37Rv (MIC₉₀ = 1.24 μM) and intracellular efficacy (EC₅₀ = 2.93 μM) with low cytotoxicity (CC₅₀ > 40 μM). In a dormancy model, sCNH240 reduced CFU by 1 log₁₀ alone and 4 log₁₀ when combined with BPaL, likely via Rv1625c/Cya activation[1]. |
| In vivo | After oral dosing (20 mg/kg) in mice, sCNH240 showed 78% bioavailability and maintained plasma levels above EC₅₀ for over 14 hours. IV dosing showed low clearance and no cardiotoxicity (hERG IC₅₀ > 30 μM)[1]. |
| Synonyms | 2-Fluoro-N-[3-(3-thienyl)-5-isoxazolyl]benzenesulfonamide |
| Molecular Weight | 324.35 |
| Formula | C13H9FN2O3S2 |
| Cas No. | 1357746-77-0 |
| Smiles | O=S(=O)(NC=1ON=C(C1)C2=CSC=C2)C=3C=CC=CC3F |
| Relative Density. | no data available |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 16.66 mg/mL (51.36 mM), Sonication is recommended.  DMSO: 50 mg/mL (154.15 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy sCNH240 | purchase sCNH240 | sCNH240 cost | order sCNH240 | sCNH240 chemical structure | sCNH240 in vivo | sCNH240 in vitro | sCNH240 formula | sCNH240 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.